Having consistently delivered accelerated market access for complex medical innovations, I am particularly drawn to the Regulatory Strategy Manager role at Synergy Health Systems. At Deloitte Consulting LLP, I recently spearheaded a comprehensive regulatory submission strategy for a novel Class III medical device, reducing its pre-market approval timeline by 35%. This involved meticulous adherence to 21 CFR Part 814 and strategic engagement with FDA Pre-Submission protocols, effectively bypassing potential delays and facilitating earlier patient access to a critical diagnostic tool amidst evolving agency guidance.
At Deloitte, my responsibilities consistently involved delivering tangible regulatory advantages. I developed and implemented a GxP audit program for a major biopharmaceutical client, identifying 12 critical non-compliance gaps across GCP and GMP. My subsequent recommendations, deeply rooted in ICH E6(R2) and 21 CFR Part 210/211, proactively reduced their potential FDA audit findings by 60% and substantially bolstered data integrity across clinical trials and manufacturing operations. Furthermore, I led global regulatory intelligence efforts that informed market entry strategies for five new pharmaceutical products in the EU and APAC regions, ensuring alignment with EMA guidelines and country-specific legislation.
My deep understanding of global regulatory frameworks and strategic risk mitigation aligns perfectly with Synergy Health Systems' mission to innovate within complex healthcare sectors. I am particularly impressed by your recent advancements in AI-driven diagnostics, a field requiring nuanced navigation of FDA and HIPAA regulations. My expertise in proactive regulatory intelligence and translating complex 21 CFR Parts into actionable strategies will be instrumental in accelerating your product pipeline while ensuring robust compliance and data security for these cutting-edge solutions, a critical strength I bring to your team.
My extensive experience leading intricate regulatory projects, coupled with a proactive approach to compliance and market access, positions me as an ideal candidate to contribute significantly to Synergy Health Systems. I am confident my strategic acumen and hands-on experience with FDA, EMA, and ICH guidelines will help your organization achieve its ambitious growth objectives. I welcome the opportunity to discuss how my qualifications can directly support your team’s regulatory successes and look forward to speaking with you soon.
Best regards,
Liam Murphy